What Is Irisin? Functions, Benefits, and How to Boost It

Irisin is a hormone-like molecule released mainly by skeletal muscle during exercise, and it acts on tissues throughout the body, from fat and bone to the brain and blood vessels. First identified in 2012 by a team at Harvard, it was named after Iris, the Greek messenger goddess, because it carries signals from working muscles to distant organs. Irisin’s discovery helped explain something researchers had long suspected: that physical activity does more than burn calories locally, it sends chemical messages that reshape metabolism elsewhere. The science has expanded rapidly since then, though translating lab findings into practical advice still requires some caution.

How Irisin Was Discovered

The story begins with a protein called PGC1-α, which ramps up in muscle cells during exercise and plays a central role in energy metabolism. In 2012, Bruce Spiegelman’s lab at Harvard showed that PGC1-α drives the production of a membrane protein called FNDC5. A fragment of FNDC5 gets cleaved off and released into the bloodstream, and that fragment is irisin.¹ What made the discovery exciting was irisin’s apparent ability to transform white fat cells into something resembling brown fat cells, which burn energy as heat instead of storing it. The original paper in mice kicked off a wave of research across dozens of organ systems.

The finding was not without controversy. Some researchers questioned whether irisin actually circulated in meaningful amounts in humans, partly because the FNDC5 gene in humans uses an unusual start codon that was thought to reduce how much of the protein gets made. That debate was largely settled in 2015, when mass spectrometry confirmed that irisin does circulate in human blood, at roughly 3.6 nanograms per milliliter in sedentary people and about 4.3 nanograms per milliliter in people doing aerobic interval training.² Those concentrations are small, but they’re real, and the roughly 20 percent bump from exercise appears consistent enough to study.

How Irisin Talks to Cells

For years after irisin’s discovery, nobody knew what receptor it used. That changed in 2018 when researchers identified αV integrins, particularly the αVβ5 subtype, as the docking site. Blocking these integrins with chemical inhibitors shut down irisin’s effects on both fat cells and bone cells.³ Integrins are proteins that sit on the surface of cells and link the outside environment to internal signaling machinery. When irisin binds to them, it triggers a cascade involving a molecule called focal adhesion kinase, which then activates downstream pathways that differ depending on the tissue.⁴

This receptor discovery matters because it explains how a single molecule released by muscles can have such varied effects. Integrin αV subtypes exist on fat cells, bone-forming cells, immune cells, neurons, and blood vessel walls. Irisin doesn’t need a different receptor for each tissue; it plugs into the same family of surface proteins and lets local cellular context determine what happens next.

Turning White Fat into a Calorie Burner

The function that put irisin on the map is its ability to “brown” white fat. White fat stores energy. Brown fat burns it, generating heat through a protein called UCP1. Irisin pushes white fat cells to crank up UCP1 expression and increase their energy expenditure, essentially making them behave more like brown fat. In human fat tissue samples, irisin treatment boosted UCP1 protein levels and elevated cellular energy metabolism.⁵ The same study showed that this browning process works through the ERK and p38 MAPK signaling pathways in human subcutaneous fat.

In human fat cells, irisin also reduced overall lipid accumulation and ramped up the expression of metabolic enzymes, suggesting it doesn’t just make fat cells burn hotter but also makes them less likely to hoard energy in the first place.⁶ This dual effect is part of why irisin has attracted so much interest in obesity research, although the gap between cell-culture results and real-world weight loss in living people remains large.

Glucose, Insulin, and Metabolic Health

Beyond fat tissue, irisin appears to help muscle cells absorb glucose. In skeletal muscle cells, irisin promotes the movement of the glucose transporter GLUT4 to the cell surface, the same step that insulin triggers to clear sugar from the blood. Blocking the p38 MAPK pathway suppressed this effect, suggesting that irisin and insulin share some downstream machinery but arrive at it through partly different routes.⁷

People with type 2 diabetes consistently show lower circulating irisin. A meta-analysis pooling data across multiple studies found that irisin levels were meaningfully reduced in people with type 2 diabetes compared to healthy controls.⁸ A separate study confirmed this pattern regardless of whether the diabetic individuals were lean or overweight, finding roughly a 15 to 18 percent decrease in irisin compared to non-diabetic people.⁹ Whether low irisin contributes to causing diabetes or is simply a consequence of the metabolic dysfunction that comes with it isn’t fully settled, but the association is robust enough to be taken seriously as a biomarker.

Effects on Blood Vessels and Blood Pressure

In animal models of hypertension, irisin lowers blood pressure by improving how blood vessels relax. In spontaneously hypertensive rats, irisin administration increased nitric oxide production in the cells lining blood vessels, leading to improved vessel dilation through the AMPK-Akt-eNOS-NO pathway.¹⁰ A separate study in mice found that irisin relaxes mesenteric arteries in a concentration-dependent way, through both the vessel lining and the smooth muscle beneath it.¹¹

These are animal results, and the doses used in rodent studies don’t translate neatly to what happens in humans during a jog. But they help explain one of the many pathways through which exercise protects cardiovascular health. The nitric oxide connection is particularly interesting because impaired nitric oxide signaling is a hallmark of endothelial dysfunction, the earliest detectable stage of atherosclerosis.

Brain Protection and Alzheimer’s Research

One of the more striking findings about irisin is that it crosses the blood-brain barrier and ramps up production of brain-derived neurotrophic factor (BDNF) in the hippocampus, the brain region most critical for memory.¹² BDNF supports the survival of existing neurons and encourages the growth of new ones. This connection has made irisin a prime candidate for explaining why exercise appears to protect against cognitive decline.

In Alzheimer’s disease models, irisin reduces amyloid-beta pathology by boosting the activity of neprilysin, an enzyme secreted by brain support cells called astrocytes that breaks down amyloid plaques.¹³ Irisin also appears to lower levels of inflammatory molecules in the brain, reduce tau protein accumulation, and improve neuronal survival and synaptic plasticity.¹⁴ In a mouse model of brain hemorrhage, irisin treatment reduced neuroinflammation and cell death, and these protective effects were blocked when the αVβ5 integrin receptor was inhibited, confirming that the same receptor mechanism identified in fat and bone also operates in the brain.¹⁵

Recent work with recombinant (lab-made) irisin in middle-aged rats that experienced stroke showed that irisin treatment altered gene expression in the brain and protected against damage from interrupted blood flow.¹⁶ None of this has been tested as a therapy in humans yet, but the consistency of findings across different brain injury models keeps drawing research attention.

Bone Health

Irisin promotes the growth and maturation of osteoblasts, the cells that build new bone. It encourages osteoblast proliferation, differentiation, and the mineralization process that hardens bone tissue, mainly through the ERK, p38, and AMPK signaling pathways.¹⁷ This has made irisin a subject of interest in osteoporosis research, particularly for postmenopausal women who face accelerated bone loss from estrogen decline. A review exploring this specifically noted that no study has yet examined how irisin, whether from exercise or administered as a drug, could reduce the severity of metabolic syndrome in postmenopausal women, highlighting a gap in clinical knowledge.¹⁸

The connection between exercise, irisin, and bone density helps explain why weight-bearing activity is the single most effective lifestyle intervention for preventing osteoporosis. The effect isn’t just about mechanical loading on the skeleton; there’s a chemical messenger reinforcing the signal.

How to Boost Irisin Levels

Exercise is the most reliable way to increase circulating irisin, but the type and intensity of exercise matter. High-intensity interval training appears to have an edge. In a crossover trial with youth of various body weights, a single session of HIIT increased circulating irisin by about 81 percent in healthy-weight participants.¹⁹ In overweight female adolescents, a session of HIIT significantly increased irisin expression in skeletal muscle, while steady-state aerobic exercise did not.²⁰

That said, the picture is not entirely clear-cut. An eight-week trial comparing aerobic exercise, resistance training, and combined exercise in women with metabolic syndrome found no statistically significant differences in circulating irisin between any of the exercise groups.²¹ The discrepancy probably reflects the difference between acute responses and chronic adaptations. A single intense workout can spike irisin sharply, but over weeks of regular training, baseline levels may not shift much. This is consistent with how many exercise-related hormones behave: the body responds to each bout but doesn’t necessarily reset its resting set-point.

The practical takeaway is that if you’re trying to maximize irisin release during each workout, higher-intensity efforts appear to be more effective. But don’t read that as evidence that moderate exercise is useless. The overall metabolic benefits of regular physical activity of any intensity extend well beyond any single molecule.

Cold Exposure and Shivering

Exercise isn’t the only trigger. Cold exposure, specifically shivering, raises circulating irisin by about as much as exercise does. In a study of seven subjects exposed to cold conditions, irisin levels rose in proportion to shivering intensity, with a strong correlation between the two.²² Interestingly, even though the energy expenditure from maximal exercise far exceeded that from cold exposure (about tenfold greater), the irisin response was similar in magnitude, suggesting that cold-specific signals beyond muscle contraction also help drive irisin release during shivering.²³

This connection between cold and irisin makes evolutionary sense. Before heated homes and insulated clothing, staying warm in winter required the body to burn more energy. A hormone that both responds to muscle shivering and triggers fat browning would have been a useful survival tool. It also helps explain the recent popular interest in cold showers and ice baths, although the evidence that brief voluntary cold exposure is intense or sustained enough to meaningfully alter irisin levels in a way that produces lasting metabolic benefits remains thin.

What About Diet and Supplements?

You might wonder whether specific foods or supplements can raise irisin. The short answer is that the evidence is disappointing so far. A study in rats testing resveratrol, grape juice, and red wine found no significant differences in plasma irisin levels across any of the treatment groups.²⁴ No dietary compound has been convincingly shown to boost irisin in humans. Supplement marketers have latched onto the concept anyway, but there are currently no irisin supplements that deliver the actual protein in a bioactive form. If you see a product claiming to “boost irisin,” treat the claim with skepticism. Muscle contraction and shivering remain the only well-documented triggers.

Cancer Research

Irisin’s reach extends into oncology, at least in lab dishes. In pancreatic cancer cells, irisin inhibited growth in a dose-dependent fashion, arrested the cell cycle, and reduced the ability of cancer cells to migrate. It also reversed a process called epithelial-mesenchymal transition, which is how cancer cells become more invasive. These effects were linked to activation of the AMPK pathway and suppression of mTOR signaling, a growth-promoting pathway that many existing cancer drugs target.²⁵

It would be premature to call irisin an anti-cancer agent based on cell-line experiments alone. Many molecules kill cancer cells in a dish but fail in animal models or human trials. Still, the finding feeds into a broader question about why regular exercise is associated with lower rates of several cancers. Irisin may be one piece of that puzzle, working alongside other exercise-induced molecules to create a systemic environment less hospitable to tumor growth.

An Ancient Molecule

One reason researchers take irisin seriously despite the relatively early stage of human evidence is how deeply conserved it is across species. A genetic screen in fruit flies identified a gene called Iditarod that shows substantial protein similarity to mammalian FNDC5 and plays a role in autophagy, the cellular housekeeping process that clears out damaged components. The researchers concluded that the Iditarod/Irisin/FNDC5 protein family has an ancient role in autophagy, exercise physiology, and cold adaptation that has been conserved across the animal kingdom.²⁶ When a molecule persists across hundreds of millions of years of evolution, from insects to humans, that conservation implies it serves a function important enough that natural selection kept it around. It also suggests that irisin’s effects aren’t limited to one or two tissues but are woven into fundamental metabolic and stress-response pathways.

Muscle Effects Beyond Endurance

Although irisin is best known for what it does to other tissues, it also feeds back on the muscle that produces it. In cultured human muscle cells, irisin treatment increased expression of insulin-like growth factor 1, a key growth signal, and decreased expression of myostatin, a protein that limits muscle growth. These changes occurred through the ERK signaling pathway. FNDC5 production and irisin secretion both rose during the process of muscle cell maturation, alongside PGC1-α and myogenin.⁶ In other words, irisin may help muscles grow and maintain themselves, creating a positive feedback loop where exercise releases irisin, and irisin supports the muscle tissue doing the exercising.

Measurement Challenges and Why They Matter

If you encounter conflicting claims about irisin in the popular press, the measurement problem is usually the reason. Many early studies used antibody-based assays (ELISAs) to measure irisin in blood, and different commercial kits often gave wildly different results. Some critics argued that the antibodies were detecting unrelated proteins. The mass spectrometry study that confirmed irisin’s presence in human blood was an important step because it provided a chemical fingerprint, not just an antibody reaction, proving that the specific protein fragment was genuinely circulating.²⁷ Even so, the absolute concentrations reported across studies still vary depending on the method used, which makes it hard to compare results from one lab to another. If you see a headline claiming irisin levels were “doubled” or “halved” by some intervention, the underlying numbers depend heavily on which assay was used, and the reader rarely gets told that.

This measurement inconsistency also complicates efforts to establish irisin as a clinical biomarker. Before a blood test for irisin could be used to screen for diabetes risk or track exercise adaptation, the field needs standardized assays that give consistent results across labs. That standardization hasn’t happened yet, so irisin remains primarily a research tool rather than something your doctor would order on a blood panel.